9-methylanthracene has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammerl, P; Hochreiter, R; Pittertschatscher, K; Thalhamer, J | 1 |
1 other study(ies) available for 9-methylanthracene and Leukemia
| Article | Year |
|---|---|
Quantification of histamine in blood plasma and cell culture supernatants: a validated one-step gas chromatography-mass spectrometry method.
Topics: Allergens; Animals; Anthracenes; Basophil Degranulation Test; Basophils; beta-N-Acetylhexosaminidases; Betula; Calcimycin; Calcium; Calibration; Cells, Cultured; Gas Chromatography-Mass Spectrometry; Histamine; Ionophores; Leukemia; Mice; Mice, Inbred BALB C; Pollen; Rats; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2002 |